Dr. Robert Liwski is the Medical Director of the HLA Laboratory at the Queen Elizabeth II Health Sciences Centre and Professor of Pathology at Dalhousie University in Halifax, Canada. He completed his PhD in Transplantation Immunology in 1999, his MD degree in 2003 and then went on to complete a fellowship training in Hematological Pathology in 2006, all at Dalhousie University. In 2012 he also completed the American Society for Histocompatibility and Immunogenetics (ASHI) Director Training Fellowship. Currently, Dr. Liwski is a clinician scientist with interests in transplantation immunology, ischemia reperfusion injury and optimization of diagnostic testing in transplantation. In his pursuit of optimizing and standardizing transplantation assays, Dr. Liwski has developed several HLA antibody testing methods, including the Halifaster flow cytometry crossmatch (FCXM) protocol and the Rapid Optimized Single Antigen Bead (ROB) assay.
11:15 - 12:15
|Concurrent Interactive Workshop — Virtual vs Physical Crossmatch: The pros and cons||Beads – Fast, Accurate – the Future||Bayshore D|